REPLIMUNE GROUP INC. - COMMON STOCK

Replimune Enters into Clinical Collaboration Agreement with Roche for the Development of RP3 In Colorectal Cancer and Hepatocellular Carcinoma

07 12 2022 06:30:00 提供 Nasdaq GlobeNewswire

Replimune to Present at the Piper Sandler 34th Annual Healthcare Conference

23 11 2022 08:00:00 提供 Nasdaq GlobeNewswire

Replimune to Host Virtual Investor Event on December 7, 2022

22 11 2022 08:00:01 提供 Nasdaq GlobeNewswire

Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update

03 11 2022 08:00:03 提供 Nasdaq GlobeNewswire

Replimune to Present at Two Upcoming Investor Conferences

02 11 2022 16:01:00 提供 Nasdaq GlobeNewswire

Replimune Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.

07 10 2022 08:00:00 提供 Nasdaq GlobeNewswire

Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update

04 8 2022 08:00:02 提供 Nasdaq GlobeNewswire

Replimune to Present at Two Upcoming Investor Conferences

01 8 2022 16:01:00 提供 Nasdaq GlobeNewswire

Replimune Announces the Departure of Jason Rhodes from its Board of Directors

03 6 2022 08:00:00 提供 Nasdaq GlobeNewswire

Replimune to Present at the Jefferies Healthcare Conference

02 6 2022 08:00:01 提供 Nasdaq GlobeNewswire

Replimune To Present at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

26 5 2022 17:15:00 提供 Nasdaq GlobeNewswire

Replimune Reports Fiscal Fourth Quarter and Year-Ended 2022 Financial Results and Provides Corporate Update

19 5 2022 08:00:01 提供 Nasdaq GlobeNewswire

Replimune Provides New Clinical Data, Broad Program Update and Future Development Strategy for its Tumor-Directed Oncolytic Immunotherapies

30 3 2022 07:00:01 提供 Nasdaq GlobeNewswire

Replimune to Host Virtual Investor Event on March 30, 2022

21 3 2022 08:00:01 提供 Nasdaq GlobeNewswire

Replimune to Present at the 11th Annual SVB Leerink Global Healthcare Conference

11 2 2022 08:00:00 提供 Nasdaq GlobeNewswire

Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update

03 2 2022 08:00:02 提供 Nasdaq GlobeNewswire

Replimune Announces the Departure of Dr. Otello Stampacchia from its Board of Directors

31 1 2022 16:01:00 提供 Nasdaq GlobeNewswire

Replimune Provides 2021 Year End Review and Overview of Expected 2022 Milestones

10 1 2022 07:00:02 提供 Nasdaq GlobeNewswire

Replimune to Present at the 40th Annual J.P. Morgan Healthcare Conference

04 1 2022 08:00:03 提供 Nasdaq GlobeNewswire

Replimune Appoints Christy Oliger to its Board of Directors

02 12 2021 08:00:02 提供 Nasdaq GlobeNewswire